Outlook Therapeutics, Inc. (OTLK) NASDAQ

1.83

-0.03(-1.61%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap36.88M
Enterprise Value-7.84T
P/E Ratio-1.56
PEG Ratio0.01
Price/Sales Ratio48.52
Price/Book Ratio-0
Enterprise/Revenue147,883.73
Enterprise/EBITDA-5,130.5

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-25.93
Operating Margin-43.35

Management Effectiveness

Return On Assets-2.34
Return On Equity0

Income Statement

Revenue1.41T
Revenue/Share0.05
Gross Profit57.21B
EBITDA-67.06T
Net Income-62.42T
Diluted EPS-1.79

Balance Sheet

Total Cash8.08M
Total Cash/Share0.22
Total Debt247.7B
Total Debt/Equity-0.01
Current Ratio0
Book Value Per Share-1.37M

Price History

52-Week Change24.49
52-Week High3.39
52-Week Low0.79
Moving Average 50 Days1.66
Moving Average 200 Days1.62

Statistics

Average Volume3.36M
Shares Outstanding44.42M
% Held by Institutions10.94

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMarch 14, 2024